Dual-Modal Tumor Imaging via Long-Circulating Biodegradable Core-Crosslinked Polymeric Micelles

Area of Science:

• Biomaterials Science
• Nanotechnology
• Medical Imaging

Background:

• Developing effective imaging agents for tumors is crucial for early detection and treatment monitoring.
• Polymeric micelles offer tunable properties for biomedical applications.
• Biodegradable nanocarriers can improve drug delivery and reduce toxicity.

Purpose of the Study:

• To develop and characterize a long-circulating, biodegradable core-crosslinked polymeric micelle (d-CCPM) for dual-modal cancer imaging.
• To evaluate the in vivo performance of d-CCPMs in terms of circulation time, tumor accumulation, and biodistribution.
• To assess the potential of d-CCPMs as a nanocarrier platform for cancer therapy.

Main Methods:

• Synthesis of amphiphilic block-copolymer with cleavable pendent triethoxysilane.
• Formation and characterization of d-CCPMs.
• In vivo evaluation of pharmacokinetics, tumor targeting, and biodistribution in tumor-bearing models.
• Dual-modal imaging using nuclear and near-infrared fluorescence techniques.
• In vitro degradation studies at acidic pH and physiological temperature.

Main Results:

• d-CCPMs exhibited prolonged blood circulation with a half-life of 36.5 hours.
• Significant accumulation in tumors (8.5% injected dose/gram at 24 hrs) with minimal uptake in liver and spleen.
• Strong tumor signals observed via both nuclear and near-infrared fluorescence imaging.
• Achieved favorable tumor-to-organ and tumor-to-blood ratios at 48 hours post-injection.
• Confirmed in vitro degradation of d-CCPMs under acidic conditions.

Conclusions:

• The d-CCPM system is an effective dual-modal probe for cancer imaging.
• d-CCPMs demonstrate excellent tumor targeting and prolonged circulation.
• The biodegradable nature and biocompatibility suggest potential as a safe nanocarrier for anti-cancer drug delivery and therapy.